← Leaderboards
Kambiz Kalantarinia
University Of Virginia Charlottesville
$755,340
Attributed
$755,340
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $180.8K · FY2005–11$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$755,340 · 9
By mechanism
K23$704,043 · 1
M01$51,297 · 8
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Alan H. Matsumoto$1,427,636
- Roberto Ariel Gomez$14,833,197
- Joel M. Linden$14,399,863
- Eugene J Barrett$22,317,830
- Mark Douglas Okusa$24,807,098
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelDiagnosisUrineProteinsUnited States National Institutes Of HealthResourcesPilot ProjectsFundingUltrasonographyNephrologyKidneyInflammationKidney DiseasesResponseDiabetes MellitusDiabetic NephropathyBlood FlowDiabeticDesignMicrobubblesInfusion ProceduresInflammatoryHandClinical Research
Grant awards (14)
Adenosine 2A Receptor Agonist in Diabetic Nephropathy$130,809
K23 · FY2011 · DK · contact PI
Adenosine 2A Receptor Agonist in Diabetic Nephropathy$130,814
K23 · FY2010 · DK · contact PI
Adenosine 2A Receptor Agonist in Diabetic Nephropathy$50,000
K23 · FY2010 · DK · contact PI
Adenosine 2A Receptor Agonist in Diabetic Nephropathy$130,818
K23 · FY2009 · DK · contact PI
ASSESSMENT OF CHANGES IN RENAL CORTICAL AND MEDULLARY BLOOD FLOW BY CONTRAST U/S$11,699
M01 · FY2009 · RR · contact PI
URINE SCREEN OF TYPE 2 DM WITH AND WITHOUT NEPHROPATHY FOR INFLAMMATORY MARKERS$10,725
M01 · FY2009 · RR · contact PI
Adenosine 2A Receptor Agonist in Diabetic Nephropathy$130,823
K23 · FY2008 · DK · contact PI
URINE SCREEN OF TYPE 2 DM WITH AND WITHOUT NEPHROPATHY FOR INFLAMMATORY MARKERS$10,341
M01 · FY2008 · RR · contact PI
ASSESSMENT OF CHANGES IN RENAL CORTICAL AND MEDULLARY BLOOD FLOW BY CONTRAST U/S$861
M01 · FY2008 · RR · contact PI
Adenosine 2A Receptor Agonist in Diabetic Nephropathy$130,779
K23 · FY2007 · DK · contact PI
ASSESSMENT OF CHANGES IN RENAL CORTICAL AND MEDULLARY BLOOD FLOW BY CEU$8,908
M01 · FY2007 · RR · contact PI
URINE SCREEN OF TYPE 2 DM WITH AND WITHOUT NEPHROPATHY FOR INFLAMMATORY MARKERS$1,783
M01 · FY2007 · RR · contact PI
URINE SCREEN OF TYPE 2 DM WITH AND WITHOUT NEPHROPATHY FOR INFLAMMATORY MARKERS$3,830
M01 · FY2006 · RR · contact PI
URINE SCREEN OF TYPE 2 DM WITH AND WITHOUT NEPHROPATHY FOR INFLAMMATORY MARKERS$3,150
M01 · FY2005 · RR